These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. [A case of malignant lymphoma associated with diffuse pulmonary involvement successfully treated with rituximab]. Kataoka T; Ishida Y; Kurokawa R; Takeshita S; Ohta K; Nishimura Y; Yokoyama M Nihon Kokyuki Gakkai Zasshi; 2003 Dec; 41(12):899-904. PubMed ID: 14727553 [TBL] [Abstract][Full Text] [Related]
26. Intravascular lymphoma: a role for single-agent rituximab. Bazhenova L; Higginbottom P; Mason J Leuk Lymphoma; 2006 Feb; 47(2):337-41. PubMed ID: 16321868 [TBL] [Abstract][Full Text] [Related]
27. Overview of the clinical development of rituximab: first monoclonal antibody approved for the treatment of lymphoma. Grillo-López AJ; White CA; Varns C; Shen D; Wei A; McClure A; Dallaire BK Semin Oncol; 1999 Oct; 26(5 Suppl 14):66-73. PubMed ID: 10561020 [TBL] [Abstract][Full Text] [Related]
28. 14-day variant of the bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone regimen in advanced-stage Hodgkin's lymphoma: results of a pilot study of the German Hodgkin's Lymphoma Study Group. Sieber M; Bredenfeld H; Josting A; Reineke T; Rueffer U; Koch T; Naumann R; Boissevain F; Koch P; Worst P; Soekler M; Eich H; Müller-Hermelink HK; Franklin J; Paulus U; Wolf J; Engert A; Diehl V; J Clin Oncol; 2003 May; 21(9):1734-9. PubMed ID: 12721249 [TBL] [Abstract][Full Text] [Related]
29. Follicular lymphoma: 2012 update on diagnosis and management. Freedman A Am J Hematol; 2012 Oct; 87(10):988-95. PubMed ID: 23001911 [TBL] [Abstract][Full Text] [Related]
31. Rituximab followed by cladribine in the treatment of heavily pretreated patients with indolent lymphoid malignancies. Robak T; Smolewski P; Urbanska-Rys H; Gora-Tybor J; Blonski JZ; Kasznicki M Leuk Lymphoma; 2004 May; 45(5):937-44. PubMed ID: 15291352 [TBL] [Abstract][Full Text] [Related]
32. Rituximab and chemotherapy is highly effective in patients with CD20-positive non-Hodgkin's lymphoma and HIV infection. Spina M; Sparano JA; Jaeger U; Rossi G; Tirelli U AIDS; 2003 Jan; 17(1):137-8. PubMed ID: 12478085 [No Abstract] [Full Text] [Related]
33. Rituximab as first-line and maintenance therapy for patients with indolent non-Hodgkin's lymphoma: interim follow-up of a multicenter phase II trial. Hainsworth JD Semin Oncol; 2002 Feb; 29(1 Suppl 2):25-9. PubMed ID: 11842385 [TBL] [Abstract][Full Text] [Related]
34. Rapid regression of chemotherapy refractory lymphocyte predominant Hodgkin's disease after administration of rituximab (anti CD 20 mono- clonal antibody) and interleukin-2. Keilholz U; Szelényi H; Siehl J; Foss HD; Knauf W; Thiel E Leuk Lymphoma; 1999 Nov; 35(5-6):641-2. PubMed ID: 10609806 [No Abstract] [Full Text] [Related]
35. Lymphoplasmacytic lymphoma with monoclonal gammopathy-related pseudo-Gaucher cell infiltration in bone marrow and spleen--diagnostic and therapeutic dilemmas. Robak T; Urbańska-Ryś H; Jerzmanowski P; Bartkowiak J; Liberski P; Kordek R Leuk Lymphoma; 2002 Dec; 43(12):2343-50. PubMed ID: 12613522 [TBL] [Abstract][Full Text] [Related]
36. CD20 role in pathophysiology of Hodgkin's disease. Santos MAO; Lima MM Rev Assoc Med Bras (1992); 2017 Sep; 63(9):810-813. PubMed ID: 29239464 [TBL] [Abstract][Full Text] [Related]
37. A systematic review and meta-analysis of immunochemotherapy with rituximab for B-cell non-Hodgkin's lymphoma. Gao G; Liang X; Jiang J; Zhou X; Huang R; Chu Z; Zhan Q Acta Oncol; 2010; 49(1):3-12. PubMed ID: 19714523 [TBL] [Abstract][Full Text] [Related]
38. BEACOPP escalated and rituximab in the treatment of Hodgkin lymphoma occurring concurrently with diffuse large B-cell non-Hodgkin lymphoma. Palickova M; Mocikova H; Vernerova Z; Campr V; Kozak T Leuk Lymphoma; 2013 Sep; 54(9):2081-2. PubMed ID: 23311295 [No Abstract] [Full Text] [Related]
39. Antilymphoma effects of anti-HLA-DR and CD20 monoclonal antibodies (Lym-1 and Rituximab) on human lymphoma cells. Liu C; DeNardo G; Tobin E; DeNardo S Cancer Biother Radiopharm; 2004 Oct; 19(5):545-61. PubMed ID: 15650447 [TBL] [Abstract][Full Text] [Related]
40. Gastric non-Hodgkin's lymphoma after successful treatment of Hodgkin's disease. Eridani S; Singh AK Oncology; 1986; 43(2):107-9. PubMed ID: 3754040 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]